We recently described conditions for safe 18-h manufacturer-to-patient transportation of freshly harvested hBM-MSC expanded under cGMP protocols using human platelet lysate (hPL), that allowed prompt use as an advanced therapeutic medicinal product. Here we outline important considerations when comparing different transportation conditions, highlighting that although cell transportation may involve a reduction in viability, this did not undermine the ultimate bone-forming regenerative potential of the cGMP-hBM-MSC population.
cGMP-compliant transportation conditions for a prompt therapeutic use of marrow mesenchymal stromal/stem cells / Veronesi, Elena; Burns, Jorge Phillip Joaquin Sans; Murgia, Alba; Candini, Olivia; Rasini, Valeria; Mastrolia, Ilenia; Catani, Fabio; Paolucci, Paolo; Dominici, Massimo. - STAMPA. - 1283:(2015), pp. 109-122. [10.1007/7651_2014_105]
cGMP-compliant transportation conditions for a prompt therapeutic use of marrow mesenchymal stromal/stem cells
VERONESI, Elena;BURNS, Jorge Phillip Joaquin Sans;MURGIA, ALBA;CANDINI, Olivia;RASINI, Valeria;MASTROLIA, ILENIA;CATANI, Fabio;PAOLUCCI, Paolo;DOMINICI, Massimo
2015
Abstract
We recently described conditions for safe 18-h manufacturer-to-patient transportation of freshly harvested hBM-MSC expanded under cGMP protocols using human platelet lysate (hPL), that allowed prompt use as an advanced therapeutic medicinal product. Here we outline important considerations when comparing different transportation conditions, highlighting that although cell transportation may involve a reduction in viability, this did not undermine the ultimate bone-forming regenerative potential of the cGMP-hBM-MSC population.File | Dimensione | Formato | |
---|---|---|---|
Veronesi et al 2014 36.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
286.67 kB
Formato
Adobe PDF
|
286.67 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris